Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Takuma

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 4, 2008
[Regulatory sciences in herbal medicines and dietary supplements]Kiichiro Tsutani, Hiroki Takuma
Pharmacoeconomics|April 10, 2009
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in JapanAtaru Igarashi, Hiroki Takuma, Takashi Fukuda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 9, 2010
Acceptable incremental cost effectiveness ratio for use of new drugs, cases in statin therapiesSusumu Nakao, Hiroyuki Kawabe, Hiroki Takuma, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 2, 2009
[Patient needs for consultation with pharmacists]Fumihiro Someya, Hiroki Takuma, Megumi Izumisawa, et al.
Journal of Molecular Biology|February 28, 2002
Crystal structure of activated ribulose-1,5-bisphosphate carboxylase/oxygenase from green alga Chlamydomonas reinhardtii complexed with 2-carboxyarabinitol-1,5-bisphosphateEiichi Mizohata, Hiroyoshi Matsumura, Yousuke Okano, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 4, 2008
[Regulatory sciences in herbal medicines and dietary supplements]Kiichiro Tsutani, Hiroki Takuma
Pharmacoeconomics|April 10, 2009
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in JapanAtaru Igarashi, Hiroki Takuma, Takashi Fukuda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 9, 2010
Acceptable incremental cost effectiveness ratio for use of new drugs, cases in statin therapiesSusumu Nakao, Hiroyuki Kawabe, Hiroki Takuma, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 2, 2009
[Patient needs for consultation with pharmacists]Fumihiro Someya, Hiroki Takuma, Megumi Izumisawa, et al.
Journal of Molecular Biology|February 28, 2002
Crystal structure of activated ribulose-1,5-bisphosphate carboxylase/oxygenase from green alga Chlamydomonas reinhardtii complexed with 2-carboxyarabinitol-1,5-bisphosphateEiichi Mizohata, Hiroyoshi Matsumura, Yousuke Okano, et al.
Pageof 1